Although diabetic retinopathy and DME are traditionally considered to be microvascular complications with VEGF representing a key therapeutic target, there is increasing evidence that chronic hyperglycemia in diabetes may trigger intraretinal neuroinflammation, neuronal degeneration, and retinal ischemia that precede microvascular, anatomical, and functional changes [65]. This evidence concerns the gene VEGFA and diabetic retinopathy.